INDEX / DIRECTORY / JOHNSON & JOHNSON / V-POL

Johnson & Johnson V-POL

POLITICAL AUDIT UPDATED 2026-06-02
V-POL Score 2.00 /10 C Johnson & Johnson — BDS-1000 448
V-POL 2.00

Evidence-only forensic audit. Scoring happens downstream — see the main dossier for the composite assessment.

V-POL Audit: Johnson & Johnson

Corporate Communications & Public Stance

Johnson & Johnson made a $2 million donation to humanitarian relief following the October 7, 2023 Hamas attacks and condemned the attacks while speaking out against antisemitism 1. No press release was identified specifically naming Gaza, Palestine, or describing the humanitarian situation beyond the initial $2 million donation response 1.

J&J has not issued a named, conflict-specific public statement addressing the Israel-Palestine conflict, Gaza hostilities, or Palestinian civilian harm 1. This contrasts with J&J’s documented statements on Russia-Ukraine (March 2022 — suspension of new business in Russia, humanitarian medicine supply to Ukraine), George Floyd/racial justice (2020 — $100 million commitment), and COVID-19 global access (2021) 1.

In SEC 10-K filings, Israel is referenced as an operating market for MedTech and Pharmaceutical segments using standard commercial jurisdiction language without geopolitical characterization 1. J&J’s Israel operations are publicly framed as R&D partnership and innovation ecosystem activity, centered on JLabs Tel Aviv 1.

Operations in Occupied or Contested Territories

J&J operates four sub-companies in Israel with over 1,000 employees 2. The company opened its first operating company in Israel in 1996 1. Operations span R&D and commercial activities across pharmaceutical, medical device, and consumer health segments 3.

J-C Health Care Ltd. and Omrix Biopharmaceuticals Ltd. are listed as J&J subsidiaries in SEC filings 45. Omrix was acquired by J&J and produces biological glue products 5.

J&J Innovation operates JLabs Tel Aviv, part of the global JLabs network, established in collaboration with Israeli academic institutions 36. FutuRx Biopharma Incubator is a J&J-partnered public-private biotechnology incubator at Weizmann Science Park, Rehovot, co-funded by Office of Chief Scientist, Takeda, and OrbiMed Israel Partners 6.

Biosense Webster (Haifa) is a J&J subsidiary acquired in 1997, manufacturing medical devices with approximately 100 employees 7.

No public evidence was identified that J&J directly operates facilities, sales offices, or service infrastructure within Israeli settlements in the occupied West Bank or East Jerusalem 18. The distinction between Israeli domestic operations (pre-1967 borders) and settlement-territory operations is not granularly disclosed in corporate filings.

J&J was not identified in search results for the 158-company UN Human Rights Office database of businesses involved in Israeli settlement activity 8. Who Profits does not have a dedicated company profile for Johnson & Johnson accessible at this time 9.

BDS India lists J&J as a boycott target citing company ownership in Israel 10. Disoccupied.com lists J&J as a company to boycott 11. No evidence was identified of J&J appearing on the main BDS Movement “Act Now” target list 1011.

No OECD National Contact Point complaints, formal legal actions, or international body rulings specifically targeting J&J’s territorial operations in occupied Palestinian territory were identified 1.

Internal Governance, Content & Retail Policies

No public evidence was identified of documented HR enforcement actions, disciplinary proceedings, or legal cases at Johnson & Johnson specifically concerning employee speech, display of political symbols, or union activity related to the Israel-Palestine conflict 1.

J&J is a pharmaceutical/medical device company and does not operate a public editorial or content platform, rendering content and editorial policy provisions not applicable 1.

J&J’s supply chain transparency reports address broader human rights and sourcing standards but do not contain specific disclosures regarding products originating from Israeli settlements or occupied Palestinian territory 1. No regulatory actions or consumer complaints specifically targeting J&J for mislabeling of settlement-origin products were identified 1.

J&J’s global public policy and government affairs disclosures and its Credo (authored by Robert Wood Johnson II in 1943) contain no articulated policy specific to the Israel-Palestine conflict or commercial activity in contested territories 1.

Brand Heritage & State Partnerships

J&J’s commercial branding is built around healthcare and consumer wellness heritage — the Credo and family health positioning. No military heritage, defense sector origins, or state-security narratives are employed in commercial branding 1.

The Office of the Chief Scientist (now Israel Innovation Authority) awarded the tender and provided approximately $2 million in government funding to establish the JLabs incubator in Israel 1213.

No public evidence was identified of J&J accepting formal state honors from the Israeli government or participating as a named corporate sponsor in Israeli government “Brand Israel” public diplomacy campaigns 1.

JLabs Tel Aviv has been supported through partnerships with Israeli academic institutions and investment bodies 36. Start-Up Nation Central documents it as a node in the Israeli innovation ecosystem 3.

Lobbying, Advocacy, Financing & Logistics

J&J maintains substantial corporate lobbying operations in the United States, with annual lobbying expenditure of approximately $9–11 million (2020–2023), focused on domestic U.S. issues including drug pricing, patent/IP policy, FDA regulation, and tort reform 14. No public evidence was identified in Senate LDA filings of registered lobbying activity on Israel-specific legislation, anti-BDS legislation, or U.S.-Israel trade policy 14.

J&J PAC (FEC ID C00010983) makes contributions across both parties. In the 2023-2024 cycle, the PAC raised $1,105,556 and contributed $519,500 total: 45.14% to Democrats ($234,500), 55.44% to Republicans ($288,000) 141516. Top recipients included Bonnie Watson Coleman (D-NJ), Brian Fitzpatrick (R-PA), Brett Guthrie (R-KY), Frank Pallone Jr. (D-NJ), Scott Peters (D-CA), Steve Scalise (R-LA), Mike Johnson (R-LA), and Mitch McConnell (R-KY) at various amounts up to $10,000 15.

No public evidence was identified of corporate-level J&J donations to FIDF, JNF/KKL, or other parastatal or settlement-linked organizations 1.

Following the October 7, 2023 Hamas attack, J&J made a $2 million humanitarian donation. No evidence was identified of specific product donations, logistics, or infrastructure credits directed to IDF, Israeli government, or Gaza-related efforts beyond this general humanitarian commitment 1. This contrasts with J&J’s Ukraine response involving specific named product donations and Russian operation suspension 1.

J&J holds a $260 million contract (2017-2022) for orthopedic products to the U.S. military via the Defense Logistics Agency, and a $60 million contract for dental/medical equipment 17. No specific Israeli Ministry of Defense contracts were identified 1.

Corporate Structure & Primary Mission

Johnson & Johnson was incorporated in New Jersey in 1887. Its corporate charter is a standard commercial corporation charter under New Jersey law. There is no state-held golden share, sovereign wealth fund ownership stake, or government-directed founding mandate 1.

J&J is a publicly traded company (NYSE: JNJ). No sovereign wealth fund, state entity, or government body holds a disclosed controlling or golden-share stake. Institutional holders include Vanguard, BlackRock, and State Street in standard index-fund proportions 1.

In 2023, J&J completed the spinoff of its consumer health division as Kenvue (NYSE: KVUE), retaining the Innovative Medicine (pharmaceuticals) and MedTech segments 1.

Executive & Leadership Footprint

Joaquin Duato became CEO in January 2022 18. No public evidence was identified of personal donations to FIDF, JNF, Israeli settlement organizations, or named pro-Israel advocacy groups. No public evidence identified of CEO Duato making public statements, posting on social media, or signing open letters regarding the Israel-Palestine conflict 18.

Prior CEO Alex Gorsky (CEO 2012–2021) — No public evidence identified of personal donations to FIDF, JNF, or settlement organizations, or of named public statements on the Israel-Palestine conflict 1.

Amir Blatt, Principal Venture Investments at JJDC, is based in Shefayim, Israel, and is a Technion graduate 19. Gilad Glick, Vice President Venture Investments at J&J, is based in Israel and was former CEO of Itamar Medical 20.

No public evidence was identified in DEF 14A proxy filings of current board members or C-suite executives holding personal leadership roles or named board seats in FIDF, JNF, AIPAC, or equivalent geopolitical pressure organizations related to Israel-Palestine 1.

The Robert Wood Johnson Foundation is a major U.S. health-focused philanthropy with $13.4 billion assets and $622 million in giving (2024) 21. No public evidence was identified of RWJF grants directed toward Israeli parastatal, settlement, or military-welfare organizations 21.

End Notes

Footnotes

  1. https://www.foxbusiness.com/lifestyle/pharma-giant-adds-israel-list-middle-east-markets-omission-raises-questions ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22 ↩23 ↩24 ↩25

  2. https://www.careers.jnj.com/en/locations/emea/israel ↩

  3. https://finder.startupnationcentral.org/mnc_page/johnson-johnson ↩ ↩2 ↩3 ↩4

  4. https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/d281803dex21.htm ↩

  5. https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/ex21-subsidiariesxform10xk.htm ↩ ↩2

  6. https://www.jnj.com/media-center/press-releases/johnson-johnson-innovation-expands-global-incubator-presence-to-israel-and-announces-multiple-diverse-early-stage-collaborations-with-academia-and-biotech ↩ ↩2 ↩3

  7. https://en.wikipedia.org/wiki/Johnson_%26_Johnson ↩

  8. https://www.ohchr.org/en/business/bhr-database ↩ ↩2

  9. https://www.whoprofits.org/company/johnson-johnson ↩

  10. https://www.instagram.com/p/DIZMev_z-QH ↩ ↩2

  11. https://disoccupied.com/brand/Johnson%20and%20Johnson/text ↩ ↩2

  12. https://www.timesofisrael.com/johnson-and-johnson-to-open-med-tech-incubator-in-israel ↩

  13. https://news.bloomberglaw.com/pharma-and-life-sciences/johnson-johnson-with-partners-opens-its-first-incubator-in-israel ↩

  14. https://www.opensecrets.org/political-action-committees-pacs/johnson-johnson/C00010983/summary/2024 ↩ ↩2 ↩3

  15. https://www.opensecrets.org/political-action-committees-pacs/johnson-johnson/C00010983/candidate-recipients/2024 ↩ ↩2

  16. https://www.fec.gov/data/committee/C00010983 ↩

  17. https://www.massdevice.com/johnson-johnson-lands-260m-defense-dept-contract-orthopedic-devices ↩

  18. https://www.jnj.com/about-jnj/management/joaquin-duato ↩ ↩2

  19. https://jnjinnovation.com/our-team/amir-blatt ↩

  20. https://jnjinnovation.com/our-team/gilad-glick ↩

  21. https://projects.propublica.org/nonprofits/organizations/226029397 ↩ ↩2